Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hammerer

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
European Urology|January 1, 1992
Digital rectal examination, imaging, and systematic-sextant biopsy in identifying operable lymph node-negative prostatic carcinomaP Hammerer, H Huland, A Sparenberg
European Urology|February 21, 1998
Thromboembolic complication rate after radical retropubic prostatectomy. Impact of routine ultrasonography for the detection of pelvic lymphoceles and hematomasH Heinzer, P Hammerer, M Graefen, et al.
Der Urologe. Ausg. A|August 25, 2000
[Chemoprevention of prostatic carcinoma]P Hammerer, M Graefen, T Steuber, et al.
Der Urologe. Ausg. A|July 1, 1995
[Perioperative and postoperative complications of pelvic lymphadenectomy and radical prostatectomy in 320 consecutive patients]P Hammerer, D Hübner, D Gonnermann, et al.
Der Urologe. Ausg. A|October 27, 2017
[Study on the prediction of AR-V7 and CTC circulation in patients with metastatic, castration-resistant prostate cancer (mCRPC) : Correlation between common clinical outcome parameters (rPFS, OS), CTC changes, and AR-V7 status (androgen receptor splice variant 7) in patients with mCRPC on first-line therapy with abiraterone acetate (STAR-V7)-study AP 96/17 of the AUO]H Rexer, P Hammerer, M Schostak, et al.
Aktuelle Urologie|September 6, 2018
H Rexer, P Hammerer, M Schostak, et al.
Der Urologe. Ausg. A|June 29, 2000
[Therapeutic options in hormone refractory prostate carcinoma]M Graefen, P Hammerer, A Haese, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Surgical therapy for localized prostatic carcinomaJ Noldus, P Hammerer, M Graefen, et al.
The Journal of Urology|March 1, 1992
Prostate cancer in nonurological patients with normal prostates on digital rectal examinationP Hammerer, V Loy, J Dieringer, et al.
The Journal of Urology|April 1, 1996
Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal, examination prostate specific antigen and the results of 6 systematic biopsiesH Huland, P Hammerer, R P Henke, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
European Urology|January 1, 1992
Digital rectal examination, imaging, and systematic-sextant biopsy in identifying operable lymph node-negative prostatic carcinomaP Hammerer, H Huland, A Sparenberg
European Urology|February 21, 1998
Thromboembolic complication rate after radical retropubic prostatectomy. Impact of routine ultrasonography for the detection of pelvic lymphoceles and hematomasH Heinzer, P Hammerer, M Graefen, et al.
Der Urologe. Ausg. A|August 25, 2000
[Chemoprevention of prostatic carcinoma]P Hammerer, M Graefen, T Steuber, et al.
Der Urologe. Ausg. A|July 1, 1995
[Perioperative and postoperative complications of pelvic lymphadenectomy and radical prostatectomy in 320 consecutive patients]P Hammerer, D Hübner, D Gonnermann, et al.
Der Urologe. Ausg. A|October 27, 2017
[Study on the prediction of AR-V7 and CTC circulation in patients with metastatic, castration-resistant prostate cancer (mCRPC) : Correlation between common clinical outcome parameters (rPFS, OS), CTC changes, and AR-V7 status (androgen receptor splice variant 7) in patients with mCRPC on first-line therapy with abiraterone acetate (STAR-V7)-study AP 96/17 of the AUO]H Rexer, P Hammerer, M Schostak, et al.
Aktuelle Urologie|September 6, 2018
H Rexer, P Hammerer, M Schostak, et al.
Der Urologe. Ausg. A|June 29, 2000
[Therapeutic options in hormone refractory prostate carcinoma]M Graefen, P Hammerer, A Haese, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Surgical therapy for localized prostatic carcinomaJ Noldus, P Hammerer, M Graefen, et al.
The Journal of Urology|March 1, 1992
Prostate cancer in nonurological patients with normal prostates on digital rectal examinationP Hammerer, V Loy, J Dieringer, et al.
The Journal of Urology|April 1, 1996
Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal, examination prostate specific antigen and the results of 6 systematic biopsiesH Huland, P Hammerer, R P Henke, et al.
Pageof 9